|
Imatinib interferes with the growth of some cancer cells. Imatinib is used to treat the blood cancer chronic myeloid leukemia (CML) and certain types of stomach cancer (stromal GI tumors or GISTs). Imatinib may also be used for purposes other ...
|
health.yahoo.com/drug/d04758a1#d04758a1-whatis
|
|
|
Imatinib - Wikipedia, the free encyclopedia
|
|
Imatinib is a drug used to treat certain types of cancer. It is currently marketed by Novartis as Gleevec (USA) or Glivec (Europe/Australia) as its mesylate salt, imatinib mesilate (INN). It wa...
en.wikipedia.org/wiki/Imatinib
|
|
|
|
|
Consumer information about the medication IMATINIB - ORAL (Gleevec), includes side effects, drug interactions, recommended dosages, and storage information. Read more about the prescription drug IMATINIB - ORAL. ... home > imatinib-oral index > imatinib-oral article...
|
www.medicinenet.com/imatinib-oral/article.htm
www.medicinenet.com/imatinib-oral/article.htm
|
|
|
|
imatinib-oral glossary includes a list of imatinib-oral related medical definitions and related links on MedicineNet.com ... home > imatinib-oral index > imatinib-oral article > glossary...
|
www.medicinenet.com/imatinib-oral/glossary.htm
www.medicinenet.com/imatinib-oral/glossary.htm
|
|
|
Learn about the prescription medication Gleevec (Imatinib Mesylate), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling. ... Imatinib is a small molecule kinase inhibitor. Gleevec film-coated tablets contain imatinib mesylate equivalent to 100 mg or 400 mg of imatinib free base.
|
www.rxlist.com/gleevec-drug.htm
|
|
Number 1 prescribed treatment for newly diagnosed adult patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) and Kit-positive gastrointestinal stromal tumors (Kit+ GIST) ... GLEEVEC® (imatinib mesylate) tablets are indicated for:
|
Congestive heart failure rarely occurs among leukemia patients who take imatinib, researchers at The University of Texas M. D. Anderson Cancer Center found after an exhaustive review of the detail ... Congestive heart failure rarely occurs among leukemia patients who take imatinib, researchers at The University of Texas M.
|
www.medicalnewstoday.com/articles/81760.php
|
|
Imatinib mesylate (also called Gleevec® or STI571) is approved by the U.S. Food and Drug Administration (FDA) for the treatment of some forms of adult and pediatric chronic myelogenous leukemia (CML), and for the treatment of a rare form of cancer called gastrointestinal stromal tumor (GIST).
|
www.cancer.gov/clinicaltrials/digestpage/gleevec
|
|
